India is set to embrace Ozempic and similar weight-loss drugs in 2026. These medications, mimicking a natural hormone, will become widely accessible, shifting the focus from vanity to treating obesity as a disorder. Doctors anticipate broader use beyond metros, impacting metabolic health and potentially reducing complications. However, responsible usage and understanding the medical benefits over cosmetic ones remain key
